Rasch MR et al. |
Chains, sheets, and droplets: assemblies of hydrophobic gold nanocrystals with saturated phosphatidylcholine lipid and squalene. |
2012 |
Langmuir |
pmid:23033891
|
Singh M et al. |
MF59 oil-in-water emulsion in combination with a synthetic TLR4 agonist (E6020) is a potent adjuvant for a combination Meningococcus vaccine. |
2012 |
Hum Vaccin Immunother |
pmid:22832252
|
Vesikari T et al. |
Assessment of squalene adjuvanted and non-adjuvanted vaccines against pandemic H1N1 influenza in children 6 months to 17 years of age. |
2012 |
Hum Vaccin Immunother |
pmid:22906943
|
Della Cioppa G et al. |
Superior immunogenicity of seasonal influenza vaccines containing full dose of MF59 (®) adjuvant: results from a dose-finding clinical trial in older adults. |
2012 |
Hum Vaccin Immunother |
pmid:22426371
|
Ikematsu H et al. |
Evaluation of immune response following one dose of an AS03A-adjuvanted H1N1 2009 pandemic influenza vaccine in Japanese adults 65 years of age or older. |
2012 |
Hum Vaccin Immunother |
pmid:22854661
|
Faenzi E et al. |
One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies. |
2012 |
Vaccine |
pmid:22521851
|
Hatz C et al. |
A randomised, single-blind, dose-range study to assess the immunogenicity and safety of a cell-culture-derived A/H1N1 influenza vaccine in adult and elderly populations. |
2012 |
Vaccine |
pmid:22626675
|
Hwang SM et al. |
Comparison of the adverse events associated with MF59-adjuvanted and non-adjuvanted H1N1 vaccines in healthy young male Korean soldiers. |
2012 |
Jpn. J. Infect. Dis. |
pmid:22627298
|
Siegrist CA et al. |
Responses of solid organ transplant recipients to the AS03-adjuvanted pandemic influenza vaccine. |
2012 |
Antivir. Ther. (Lond.) |
pmid:22544169
|
Yang M et al. |
MF59 formulated with CpG ODN as a potent adjuvant of recombinant HSP65-MUC1 for inducing anti-MUC1+ tumor immunity in mice. |
2012 |
Int. Immunopharmacol. |
pmid:22595192
|
Cabrera-Vique C et al. |
Bioactive compounds and nutritional significance of virgin argan oil--an edible oil with potential as a functional food. |
2012 |
Nutr. Rev. |
pmid:22537213
|
Stella B et al. |
Nonpolymeric nanoassemblies for ocular administration of acyclovir: pharmacokinetic evaluation in rabbits. |
2012 |
Eur J Pharm Biopharm |
pmid:22008147
|
Nakazawa A et al. |
Optimization of culture conditions of the thraustochytrid Aurantiochytrium sp. strain 18W-13a for squalene production. |
2012 |
Bioresour. Technol. |
pmid:22023965
|
Niehaus TD et al. |
Functional identification of triterpene methyltransferases from Botryococcus braunii race B. |
2012 |
J. Biol. Chem. |
pmid:22241476
|
Iorio AM et al. |
Influenza viruses and cross-reactivity in healthy adults: humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus. |
2012 |
Vaccine |
pmid:22245606
|
Ambrose CS and Belshe RB |
Influenza vaccine in young children. |
2012 |
N. Engl. J. Med. |
pmid:22276839
|
Heikkinen T and Heinonen S |
Influenza vaccine in young children. |
2012 |
N. Engl. J. Med. |
pmid:22276840
|
Gasparini R et al. |
Aflunov(®): a prepandemic influenza vaccine. |
2012 |
Expert Rev Vaccines |
pmid:22309663
|
Hoshino T et al. |
Lanosterol biosynthesis: the critical role of the methyl-29 group of 2,3-oxidosqualene for the correct folding of this substrate and for the construction of the five-membered D ring. |
2012 |
Chemistry |
pmid:22933236
|
Wilson KR et al. |
The statistical evolution of multiple generations of oxidation products in the photochemical aging of chemically reduced organic aerosol. |
2012 |
Phys Chem Chem Phys |
pmid:22158973
|
Xue Z et al. |
Divergent evolution of oxidosqualene cyclases in plants. |
2012 |
New Phytol. |
pmid:22150097
|
Oral E et al. |
A new mechanism of oxidation in ultrahigh molecular weight polyethylene caused by squalene absorption. |
2012 |
J. Biomed. Mater. Res. Part B Appl. Biomater. |
pmid:22190411
|
Sancho A et al. |
More on influenza vaccine in young children. |
2012 |
N. Engl. J. Med. |
pmid:22738111
|
Yang P et al. |
Two concise enantioselective total syntheses of (-)-glabrescol implicate alternative biosynthetic pathways starting from squalene. |
2012 |
Org. Lett. |
pmid:22817611
|
RamÃrez-Torres A et al. |
Proteomics and gene expression analyses of squalene-supplemented mice identify microsomal thioredoxin domain-containing protein 5 changes associated with hepatic steatosis. |
2012 |
J Proteomics |
pmid:22796066
|
Surls J et al. |
Increased membrane cholesterol in lymphocytes diverts T-cells toward an inflammatory response. |
2012 |
PLoS ONE |
pmid:22723880
|
Girod A et al. |
Composition of fingermark residue: a qualitative and quantitative review. |
2012 |
Forensic Sci. Int. |
pmid:22727572
|
Sarpietro MG et al. |
Squalenoyl prodrug of paclitaxel: synthesis and evaluation of its incorporation in phospholipid bilayers. |
2012 |
Int J Pharm |
pmid:22728161
|
Wu S et al. |
Engineering triterpene metabolism in tobacco. |
2012 |
Planta |
pmid:22729821
|
Langley JM et al. |
Randomized, multicenter trial of a single dose of AS03-adjuvanted or unadjuvanted H1N1 2009 pandemic influenza vaccine in children 6 months to <9 years of age: safety and immunogenicity. |
2012 |
Pediatr. Infect. Dis. J. |
pmid:22801094
|
Block SL et al. |
Dose-range study of MF59-adjuvanted versus nonadjuvanted monovalent A/H1N1 pandemic influenza vaccine in six- to less than thirty-six-month-old children. |
2012 |
Pediatr. Infect. Dis. J. |
pmid:22481427
|
Sémiramoth N et al. |
Self-assembled squalenoylated penicillin bioconjugates: an original approach for the treatment of intracellular infections. |
2012 |
ACS Nano |
pmid:22482704
|
Langley JM et al. |
Safety and immunogenicity of 2010-2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12-59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: a PHAC/CIHR Influenza Research Network (PCIRN) study. |
2012 |
Vaccine |
pmid:22469860
|
Fukase H et al. |
Assessment of the immunogenicity and safety of varying doses of an MF59®-adjuvanted cell culture-derived A/H1N1 pandemic influenza vaccine in Japanese paediatric, adult and elderly subjects. |
2012 |
Vaccine |
pmid:22472791
|
Suthiwong J et al. |
A new phenolic compound from the stem of Hymenocardia wallichii. |
2012 |
J Asian Nat Prod Res |
pmid:22423644
|
Zhang XH et al. |
Chemical composition of volatile oils from the pericarps of Indian sandalwood (Santalum album) by different extraction methods. |
2012 |
Nat Prod Commun |
pmid:22428257
|
Guzmán Herrador BR et al. |
Usefulness of health registries when estimating vaccine effectiveness during the influenza A(H1N1)pdm09 pandemic in Norway. |
2012 |
BMC Infect. Dis. |
pmid:22429643
|
Hatz C et al. |
A randomized clinical trial to identify the optimal antigen and MF59(®) adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects. |
2012 |
Vaccine |
pmid:22446638
|
Lai RP et al. |
Mixed adjuvant formulations reveal a new combination that elicit antibody response comparable to Freund's adjuvants. |
2012 |
PLoS ONE |
pmid:22509385
|
Marinaro M et al. |
A caprine herpesvirus 1 vaccine adjuvanted with MF59â„¢ protects against vaginal infection and interferes with the establishment of latency in goats. |
2012 |
PLoS ONE |
pmid:22511971
|
Calmy A et al. |
Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patients. |
2012 |
HIV Med. |
pmid:22093373
|
Dell'Era L et al. |
Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis. |
2012 |
Vaccine |
pmid:22138210
|
Allain V et al. |
Self-assembled nucleolipids: from supramolecular structure to soft nucleic acid and drug delivery devices. |
2012 |
Nucleic Acids Res. |
pmid:22075995
|
Song JY et al. |
Comparison of the long-term immunogenicity of two pandemic influenza A/H1N1 2009 vaccines, the MF59-adjuvanted and unadjuvanted vaccines, in adults. |
2012 |
Clin. Vaccine Immunol. |
pmid:22379067
|
Caproni E et al. |
MF59 and Pam3CSK4 boost adaptive responses to influenza subunit vaccine through an IFN type I-independent mechanism of action. |
2012 |
J. Immunol. |
pmid:22351935
|
Kim SK and Karadeniz F |
Biological importance and applications of squalene and squalane. |
2012 |
Adv. Food Nutr. Res. |
pmid:22361190
|
Dey AK et al. |
Use of a polyanionic carbomer, Carbopol971P, in combination with MF59, improves antibody responses to HIV-1 envelope glycoprotein. |
2012 |
Vaccine |
pmid:22366638
|
Garçon N et al. |
Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion. |
2012 |
Expert Rev Vaccines |
pmid:22380826
|
RamÃrez-Torres A et al. |
Proteomics and gene expression analyses of mitochondria from squalene-treated apoE-deficient mice identify short-chain specific acyl-CoA dehydrogenase changes associated with fatty liver amelioration. |
2012 |
J Proteomics |
pmid:22402057
|
Tronchoni J et al. |
Lipid composition of wine strains of Saccharomyces kudriavzevii and Saccharomyces cerevisiae grown at low temperature. |
2012 |
Int. J. Food Microbiol. |
pmid:22405355
|
Fox CB et al. |
Immunomodulatory and physical effects of phospholipid composition in vaccine adjuvant emulsions. |
2012 |
AAPS PharmSciTech |
pmid:22415641
|
Nassim C et al. |
Identification of antigen and adjuvant doses resulting in optimal immunogenicity and antibody persistence up to 1 year after immunization with a pandemic A/H1N1 influenza vaccine in children 3 to < 9 years of age. |
2012 |
Pediatr. Infect. Dis. J. |
pmid:22418661
|
Fox CB et al. |
Effects on immunogenicity by formulations of emulsion-based adjuvants for malaria vaccines. |
2012 |
Clin. Vaccine Immunol. |
pmid:22896687
|
Reynales H et al. |
A prospective observational safety study on MF59(®) adjuvanted cell culture-derived vaccine, Celtura(®) during the A/H1N1 (2009) influenza pandemic. |
2012 |
Vaccine |
pmid:22902681
|
Desmaële D et al. |
Squalenoylation: a generic platform for nanoparticular drug delivery. |
2012 |
J Control Release |
pmid:21840355
|
Naziri E et al. |
Recovery of squalene from wine lees using ultrasound assisted extraction-a feasibility study. |
2012 |
J. Agric. Food Chem. |
pmid:22888984
|
Liu Y et al. |
[Researches on influence of squalene synthase gene polymorphism on catalytic efficiency of its encode enzyme in Glycyrrhiza uralensis]. |
2012 |
Zhongguo Zhong Yao Za Zhi |
pmid:23627178
|
Czajka H et al. |
A phase II, randomised clinical trial to demonstrate the non-inferiority of low-dose MF59-adjuvanted pre-pandemic A/H5N1 influenza vaccine in adult and elderly subjects. |
2012 |
J Prev Med Hyg |
pmid:23362618
|
Takami T et al. |
A genetic and pharmacological analysis of isoprenoid pathway by LC-MS/MS in fission yeast. |
2012 |
PLoS ONE |
pmid:23145048
|
Langley JM et al. |
A randomized, controlled non-inferiority trial comparing A(H1N1)pmd09 vaccine antigen, with and without AS03 adjuvant system, co-administered or sequentially administered with an inactivated trivalent seasonal influenza vaccine. |
2012 |
BMC Infect. Dis. |
pmid:23110320
|
Bihari I et al. |
Assessment of antigen-specific and cross-reactive antibody responses to an MF59-adjuvanted A/H5N1 prepandemic influenza vaccine in adult and elderly subjects. |
2012 |
Clin. Vaccine Immunol. |
pmid:23081815
|
Tetsutani K and Ishii KJ |
Adjuvants in influenza vaccines. |
2012 |
Vaccine |
pmid:23084848
|
Liu YT et al. |
Protein engineering of Saccharomyces cerevisiae oxidosqualene-lanosterol cyclase into parkeol synthase. |
2012 |
Org. Lett. |
pmid:23043506
|
Yockel S and Schatz GC |
Dynamic QM/MM: a hybrid approach to simulating gas-liquid interactions. |
2012 |
Top Curr Chem |
pmid:21506003
|
Nguyen HT et al. |
Molecular characterization of Glycine max squalene synthase genes in seed phytosterol biosynthesis. |
2013 |
Plant Physiol. Biochem. |
pmid:24036394
|
Borchman D et al. |
Confirmation of the presence of squalene in human eyelid lipid by heteronuclear single quantum correlation spectroscopy. |
2013 |
Lipids |
pmid:24081494
|
Rajaram K et al. |
Comparative bioactive studies between wild plant and callus culture of Tephrosia tinctoria pers. |
2013 |
Appl. Biochem. Biotechnol. |
pmid:24026411
|
Villa M et al. |
Safety of MF59-adjuvanted influenza vaccination in the elderly: results of a comparative study of MF59-adjuvanted vaccine versus nonadjuvanted influenza vaccine in northern Italy. |
2013 |
Am. J. Epidemiol. |
pmid:23863759
|
Robinson ES et al. |
Organic aerosol mixing observed by single-particle mass spectrometry. |
2013 |
J Phys Chem A |
pmid:24131283
|
Rouleau I et al. |
Increased risk of anaphylaxis following administration of 2009 AS03-adjuvanted monovalent pandemic A/H1N1 (H1N1pdm09) vaccine. |
2013 |
Vaccine |
pmid:24144473
|
Naughton C et al. |
Transcription forms and remodels supercoiling domains unfolding large-scale chromatin structures. |
2013 |
Nat. Struct. Mol. Biol. |
pmid:23416946
|
Naziri E and Tsimidou MZ |
Formulated squalene for food related applications. |
2013 |
Recent Pat Food Nutr Agric |
pmid:23270393
|
Morimoto Y et al. |
Biomimetic epoxide-opening cascades of oxasqualenoids triggered by hydrolysis of the terminal epoxide. |
2013 |
Org. Lett. |
pmid:23721415
|
Tegenge MA and Mitkus RJ |
A physiologically-based pharmacokinetic (PBPK) model of squalene-containing adjuvant in human vaccines. |
2013 |
J Pharmacokinet Pharmacodyn |
pmid:23912214
|
Mølbak K |
[Squalene unlikely sinner]. |
2013 |
Ugeskr. Laeg. |
pmid:23833782
|
Gefenaite G et al. |
Effectiveness of A(H1N1)pdm09 influenza vaccine in adults recommended for annual influenza vaccination. |
2013 |
PLoS ONE |
pmid:23840413
|
Fox CB and Haensler J |
An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants. |
2013 |
Expert Rev Vaccines |
pmid:23885820
|
Sisco E et al. |
Evaluation of C60 secondary ion mass spectrometry for the chemical analysis and imaging of fingerprints. |
2013 |
Forensic Sci. Int. |
pmid:23890648
|
King KL et al. |
Inelastic scattering of OH radicals from organic liquids: isolating the thermal desorption channel. |
2013 |
Phys Chem Chem Phys |
pmid:23807737
|
Chandramouli S et al. |
Generation of a parvovirus B19 vaccine candidate. |
2013 |
Vaccine |
pmid:23827313
|
Song JY et al. |
Long-term and cross-reactive immunogenicity of inactivated trivalent influenza vaccine in the elderly: MF59-adjuvanted vaccine versus unadjuvanted vaccine. |
2013 |
J. Med. Virol. |
pmid:23852684
|
Yang WH et al. |
Long-term immunogenicity of an AS03-adjuvanted influenza A(H1N1)pdm09 vaccine in young and elderly adults: an observer-blind, randomized trial. |
2013 |
Vaccine |
pmid:23856331
|
Ruehl CR et al. |
The influence of molecular structure and aerosol phase on the heterogeneous oxidation of normal and branched alkanes by OH. |
2013 |
J Phys Chem A |
pmid:23611149
|
Wijnans L et al. |
Effectiveness of MF59â„¢ adjuvanted influenza A(H1N1)pdm09 vaccine in risk groups in the Netherlands. |
2013 |
PLoS ONE |
pmid:23646191
|
Gavaldà J et al. |
Immunogenicity of pandemic influenza A H1N1/2009 adjuvanted vaccine in pediatric solid organ transplant recipients. |
2013 |
Pediatr Transplant |
pmid:23692602
|
Calabro S et al. |
The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect. |
2013 |
Vaccine |
pmid:23684834
|
Bischoff AL et al. |
Altered response to A(H1N1)pnd09 vaccination in pregnant women: a single blinded randomized controlled trial. |
2013 |
PLoS ONE |
pmid:23637733
|
Kalogeropoulos N et al. |
Nutritional evaluation and health promoting activities of nuts and seeds cultivated in Greece. |
2013 |
Int J Food Sci Nutr |
pmid:23641668
|
Durier C et al. |
Long-term immunogenicity of two doses of 2009 A/H1N1v vaccine with and without AS03(A) adjuvant in HIV-1-infected adults. |
2013 |
AIDS |
pmid:23018437
|
Lin YK et al. |
Squalene-containing nanostructured lipid carriers promote percutaneous absorption and hair follicle targeting of diphencyprone for treating alopecia areata. |
2013 |
Pharm. Res. |
pmid:23070602
|
Lopez P et al. |
Combined administration of MF59-adjuvanted A/H5N1 prepandemic and seasonal influenza vaccines: long-term antibody persistence and robust booster responses 1 year after a one-dose priming schedule. |
2013 |
Clin. Vaccine Immunol. |
pmid:23536690
|
Mazein A et al. |
A comprehensive machine-readable view of the mammalian cholesterol biosynthesis pathway. |
2013 |
Biochem. Pharmacol. |
pmid:23583456
|
Lange S et al. |
Aminopropylindenes derived from Grundmann's ketone as a novel chemotype of oxidosqualene cyclase inhibitors. |
2013 |
Eur J Med Chem |
pmid:23583910
|
McElhaney JE et al. |
AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial. |
2013 |
Lancet Infect Dis |
pmid:23518156
|
Ledgerwood JE |
AS03-adjuvanted influenza vaccine in elderly people. |
2013 |
Lancet Infect Dis |
pmid:23518157
|
Hillaireau H et al. |
Anti-HIV efficacy and biodistribution of nucleoside reverse transcriptase inhibitors delivered as squalenoylated prodrug nanoassemblies. |
2013 |
Biomaterials |
pmid:23562054
|
Vera-Lastra O et al. |
Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld's syndrome): clinical and immunological spectrum. |
2013 |
Expert Rev Clin Immunol |
pmid:23557271
|
AÄimoviÄ J and Rozman D |
Steroidal triterpenes of cholesterol synthesis. |
2013 |
Molecules |
pmid:23558541
|
Segura-Velázquez R et al. |
Influenza vaccine: development of a novel intranasal and subcutaneous recombinant adjuvant. |
2013 |
Vaccine |
pmid:23746458
|
Lin YS et al. |
A real-time impedance-sensing chip for the detection of emulsion phase separation. |
2013 |
Electrophoresis |
pmid:23765861
|